BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29670109)

  • 21. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
    Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
    World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.
    Cha S; Lee J; Shin JY; Kim JY; Sim SH; Keam B; Kim TM; Kim DW; Heo DS; Lee SH; Kim JI
    BMC Cancer; 2016 Feb; 16():170. PubMed ID: 26925973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions.
    Wong JKL; Aichmüller C; Schulze M; Hlevnjak M; Elgaafary S; Lichter P; Zapatka M
    Nat Commun; 2022 Jan; 13(1):178. PubMed ID: 35013316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cis-regulatory somatic mutations and gene-expression alteration in B-cell lymphomas.
    Mathelier A; Lefebvre C; Zhang AW; Arenillas DJ; Ding J; Wasserman WW; Shah SP
    Genome Biol; 2015 Apr; 16(1):84. PubMed ID: 25903198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
    Fujimoto A; Furuta M; Totoki Y; Tsunoda T; Kato M; Shiraishi Y; Tanaka H; Taniguchi H; Kawakami Y; Ueno M; Gotoh K; Ariizumi S; Wardell CP; Hayami S; Nakamura T; Aikata H; Arihiro K; Boroevich KA; Abe T; Nakano K; Maejima K; Sasaki-Oku A; Ohsawa A; Shibuya T; Nakamura H; Hama N; Hosoda F; Arai Y; Ohashi S; Urushidate T; Nagae G; Yamamoto S; Ueda H; Tatsuno K; Ojima H; Hiraoka N; Okusaka T; Kubo M; Marubashi S; Yamada T; Hirano S; Yamamoto M; Ohdan H; Shimada K; Ishikawa O; Yamaue H; Chayama K; Miyano S; Aburatani H; Shibata T; Nakagawa H
    Nat Genet; 2016 May; 48(5):500-9. PubMed ID: 27064257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.
    Chalmers ZR; Connelly CF; Fabrizio D; Gay L; Ali SM; Ennis R; Schrock A; Campbell B; Shlien A; Chmielecki J; Huang F; He Y; Sun J; Tabori U; Kennedy M; Lieber DS; Roels S; White J; Otto GA; Ross JS; Garraway L; Miller VA; Stephens PJ; Frampton GM
    Genome Med; 2017 Apr; 9(1):34. PubMed ID: 28420421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequence dependencies and mutation rates of localized mutational processes in cancer.
    Poulsgaard GA; Sørensen SG; Juul RI; Nielsen MM; Pedersen JS
    Genome Med; 2023 Aug; 15(1):63. PubMed ID: 37592287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of open chromosomal regions and key genes in prostate cancer via integrated analysis of DNase‑seq and RNA‑seq data.
    Wei X; Yu L; Jin X; Song L; Lv Y; Han Y
    Mol Med Rep; 2018 Aug; 18(2):2245-2252. PubMed ID: 29956775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Candidate driver genes in focal chromosomal aberrations of stage II colon cancer.
    Brosens RP; Haan JC; Carvalho B; Rustenburg F; Grabsch H; Quirke P; Engel AF; Cuesta MA; Maughan N; Flens M; Meijer GA; Ylstra B
    J Pathol; 2010 Aug; 221(4):411-24. PubMed ID: 20593488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CTCF prevents genomic instability by promoting homologous recombination-directed DNA double-strand break repair.
    Lang F; Li X; Zheng W; Li Z; Lu D; Chen G; Gong D; Yang L; Fu J; Shi P; Zhou J
    Proc Natl Acad Sci U S A; 2017 Oct; 114(41):10912-10917. PubMed ID: 28973861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An analysis of mutational signatures of synonymous mutations across 15 cancer types.
    Bin Y; Wang X; Zhao L; Wen P; Xia J
    BMC Med Genet; 2019 Dec; 20(Suppl 2):190. PubMed ID: 31815613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible causes of chromosome instability: comparison of chromosomal abnormalities in cancer cell lines with mutations in BRCA1, BRCA2, CHK2 and BUB1.
    Grigorova M; Staines JM; Ozdag H; Caldas C; Edwards PA
    Cytogenet Genome Res; 2004; 104(1-4):333-40. PubMed ID: 15162061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
    Chang MT; Asthana S; Gao SP; Lee BH; Chapman JS; Kandoth C; Gao J; Socci ND; Solit DB; Olshen AB; Schultz N; Taylor BS
    Nat Biotechnol; 2016 Feb; 34(2):155-63. PubMed ID: 26619011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
    Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide single-nucleotide polymorphism arrays in endometrial carcinomas associate extensive chromosomal instability with poor prognosis and unveil frequent chromosomal imbalances involved in the PI3-kinase pathway.
    Murayama-Hosokawa S; Oda K; Nakagawa S; Ishikawa S; Yamamoto S; Shoji K; Ikeda Y; Uehara Y; Fukayama M; McCormick F; Yano T; Taketani Y; Aburatani H
    Oncogene; 2010 Apr; 29(13):1897-908. PubMed ID: 20062086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequence and structure signatures of cancer mutation hotspots in protein kinases.
    Dixit A; Yi L; Gowthaman R; Torkamani A; Schork NJ; Verkhivker GM
    PLoS One; 2009 Oct; 4(10):e7485. PubMed ID: 19834613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NIMBus: a negative binomial regression based Integrative Method for mutation Burden Analysis.
    Zhang J; Liu J; McGillivray P; Yi C; Lochovsky L; Lee D; Gerstein M
    BMC Bioinformatics; 2020 Oct; 21(1):474. PubMed ID: 33092526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive Evaluation of Protein Coding Mononucleotide Microsatellites in Microsatellite-Unstable Colorectal Cancer.
    Kondelin J; Gylfe AE; Lundgren S; Tanskanen T; Hamberg J; Aavikko M; Palin K; Ristolainen H; Katainen R; Kaasinen E; Taipale M; Taipale J; Renkonen-Sinisalo L; Järvinen H; Böhm J; Mecklin JP; Vahteristo P; Tuupanen S; Aaltonen LA; Pitkänen E
    Cancer Res; 2017 Aug; 77(15):4078-4088. PubMed ID: 28611049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interaction between cytosine methylation and processes of DNA replication and repair shape the mutational landscape of cancer genomes.
    Poulos RC; Olivier J; Wong JWH
    Nucleic Acids Res; 2017 Jul; 45(13):7786-7795. PubMed ID: 28531315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The coding region of the Bloom syndrome BLM gene and of the CBL proto-oncogene is mutated in genetically unstable sporadic gastrointestinal tumors.
    Calin G; Herlea V; Barbanti-Brodano G; Negrini M
    Cancer Res; 1998 Sep; 58(17):3777-81. PubMed ID: 9731483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.